Du är här

A Clinician View and Experience of Proteomic Studies in the Light of Lung Cancer in Japanese Healthcare

Författare:
  • Harubumi Kato
  • Toshihide Nishimura
  • Takashi Hirano
  • Masaharu Nomura
  • Hiromasa Tojo
  • Kiyonaga Fujii
  • Takeshi Kawamura
  • Sayaka Mikami
  • Makoto Kihara
  • Yasuhiko Bando
  • Masahiro Tsuboi
  • Norihiko Ikeda
  • György Marko-Varga
Publiceringsår: 2011
Språk: Engelska
Sidor: 51-57
Publikation/Tidskrift/Serie: Journal of Proteome Research
Volym: 10
Nummer: 1
Dokumenttyp: Artikel
Förlag: Amer Chemical Soc

Sammanfattning

In Japan, rising costs have impacted the framework of maintaining an efficient and effective healthcare system. Today, urgent implementation of programs to address this need have led to a rebuilding of the entire approach of medical evaluation and clinical care. Recent developments in clinical proteomics based on mass spectrometry (MS) for identifying, sequencing, and quantifying disease-relevant protein biomarkers is a promising means for optimal drug prescription using biomarker diagnosis. We illustrate in this report our experience with lung cancer cases with various drug therapies evaluated with proteomics studies.

Disputation

Nyckelord

  • Medicine and Health Sciences
  • lung cancer
  • diagnosis and treatment
  • proteomic study
  • healthcare

Övriga

Published
  • ISSN: 1535-3893

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

 

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen